Parkinsons Disease

Papers
(The TQCC of Parkinsons Disease is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods20
The Rehabilitative Effect of Archery Exercise Intervention in Patients with Parkinson’s Disease19
The Current State of Parkinsonism in West Africa: A Systematic Review17
A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease16
Movement Disorders Associated with COVID-1912
Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis10
Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson’s Disease: Online-Based Delphi Survey9
Cinnamaldehyde Attenuates the Expression of IBA1 and GFAP to Inhibit Glial Cell Activation and Inflammation in the MPTP‐Induced Acute Parkinson’s Disease Model8
Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease7
Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson’s Disease7
Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease7
Alprazolam Reduces Freezing of Gait (FOG) and Improves FOG-Related Gait Deficiencies6
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk5
Quantitative Analysis of Postural Balance in Faller and Nonfaller Patients with Parkinson’s Disease5
Occupational Therapy for People with Early Parkinson’s Disease: A Retrospective Program Evaluation5
Cognitive Impairment in Genetic Parkinson’s Disease5
Association between Cognitive Impairment and Hippocampal Subfield Volumes in Multiple System Atrophy5
The Origin of Abnormal Beta Oscillations in the Parkinsonian Corticobasal Ganglia Circuits5
Improvement by Medication Less than Expected in Parkinson’s Disease: Blinded Evaluation of Levodopa Response5
Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS)5
Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease5
Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life5
Protective Role of AMPK against PINK1B9 Flies’ Neurodegeneration with Improved Mitochondrial Function4
Validity and Reliability of the Persian Version of Parkinson’s Disease Sleep Scale-24
Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group4
Odor Identification by Parkinson’s Disease Patients Tested by Using Sniffin’ Sticks versus Natural Spices4
Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang4
Genome- and Exome-Wide Association Studies Revealed Candidate Genes Associated with DaTscan Imaging Features4
Gender Was Associated with Depression but Not with Gastrointestinal Dysfunction in Patients with Parkinson’s Disease4
Qualitative Analysis of Attitudes, Knowledge, and Interest in Research of People with Parkinson’s Disease and Their Care Partners Receiving Accessible Research Education4
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease4
The Role of Muscle Strength in the Sit-to-Stand Task in Parkinson’s Disease4
Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review4
Levodopa Prescription Patterns in Patients with Advanced Parkinson’s Disease: A Japanese Database Analysis4
Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease3
Association of p53 with Neurodegeneration in Parkinson’s Disease3
The Relationship between Visual-Evoked Potential and Optic Coherence Tomography and Clinical Findings in Parkinson Patients3
Exploring a New Cueing Device in People Who Experience Freezing of Gait: Acceptance of a Study Design3
Parkinsonics: A Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Nonmotor Symptoms in Idiopathic Parkinson Disease3
Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease3
Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson’s Disease3
Multidisciplinary Rehabilitation for People with Parkinson’s Disease: A Systematic Review and Meta-Analysis3
Telerehabilitation: A Practical Remote Alternative for Coaching and Monitoring Physical Kinetic Therapy in Patients with Mild and Moderate Disabling Parkinson’s Disease during the COVID-19 Pandemic3
Like a Wave in Its Variable Shape, Breadth, and Depth: A Qualitative Interview Study of Experiences of Daytime Sleepiness in People with Parkinson’s Disease3
Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson’s Disease in Rats3
Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study3
Orthostatic Hypotension Is a Predictor of Fatigue in Drug-Naïve Parkinson’s Disease3
Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease3
0.058727025985718